List of Thiazolidinediones (glitazones) - Drugs.com
WEBThiazolidinediones are a class of medicines that may be used for the treatment of type 2 diabetes by improving insulin sensitivity. They are also known as glitazones and have side effects such as weight gain and peripheral fat deposition.
Explore further
Thiazolidinediones - StatPearls - NCBI Bookshelf
WEBFeb 20, 2023 · Thiazolidinediones are medications used to manage and treat type 2 diabetes mellitus. These medications may be acting as a …
- Published: 2023/02/20
Thiazolidinedione - Wikipedia
The thiazolidinediones /θaɪ.əˌzoʊlɪdiːnˈdaɪ.oʊn/, abbreviated as TZD, also known as glitazones after the prototypical drug ciglitazone, are a class of heterocyclic compounds consisting of a five-membered C3NS ring. The term usually refers to a family of drugs used in the treatment of diabetes mellitus type 2 that were introduced in the late 1990s.
Wikipedia · Text under CC-BY-SA license- Estimated Reading Time: 9 mins
Thiazolidinediones in the treatment of type 2 diabetes mellitus
WEBJun 14, 2022 · Thiazolidinediones are oral medications that improve glucose metabolism by increasing insulin sensitivity. Learn about their pharmacology, use, …
Thiazolidinediones - The Johns Hopkins Patient Guide to Diabetes
WEBLearn about thiazolidinediones, oral tablets for type 2 diabetes that enhance insulin response. Find out how they work, who can take them, and what side effects to watch …
- Estimated Reading Time: 2 mins
Understanding Contemporary Use of Thiazolidinediones
WEBMay 26, 2019 · Thiazolidinediones (rosiglitazone, pioglitazone) are oral insulin-sensitizing medications used in type 2 diabetes mellitus that reduce glucose with minimal risk of …
Thiazolidinediones: the Forgotten Diabetes Medications - PMC
WEBNov 27, 2019 · Thiazolidinediones (TZDs) are the only pharmacologic agents that specifically treat insulin resistance. The beneficial effects of TZDs on the cardiovascular …
An Update on the Current and Emerging Use of …
WEBOct 17, 2022 · Abstract. Guidelines have increasingly stressed the concept that adequate glycemic control is required to prevent or decrease the macro- and microvascular …
Thiazolidinediones | New England Journal of Medicine
WEBSep 9, 2004 · Thiazolidinediones consistently lower fasting and postprandial glucose concentrations as well as free fatty acid concentrations in clinical studies. 28–31 Insulin concentrations also decrease in...
Thiazolidinedione Drugs and Cardiovascular Risks
WEBTwo thiazolidinediones are currently available in the United States, rosiglitazone (Avandia) and pioglitazone (Actos). A third thiazolidinedione, troglitazone (Rezulin), was withdrawn from the market in 2000 because …
- Some results have been removed
Skip to content